Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL...
Used to treat potentially life threatening fungal infections.
Kala-azar Medical Research Center, Rambag Road, Muzaffarpur, India
Children's National Medical Center, Washington, District of Columbia, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
University of California at San Diego, La Jolla, California, United States
Hôpital Necker - Service des Maladies Infectieuses et Tropicales, Paris, France
Necker Hospital, Paris, France
The Alfred Hosptial, Melbourne, Victoria, Australia
Box Hill Hospital, Eastern Health, Melbourne, Victoria, Australia
UCSF, San Francisco, California, United States
Duke University, Durham, North Carolina, United States
City of Hope National Medical Center, Duarte, California, United States
The University of Texas M D Anderson Cancer Center, Houston, Texas, United States
Gilead Sciences, Paris, France
Gilead Sciences, Paris, France
Gilead Sciences, Milan, Italy
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.